5. clinical practice in contraception-bus
TRANSCRIPT
-
7/25/2019 5. Clinical Practice in Contraception-BUS
1/34
! "
Budi Santoso
Departement of Obstetry Ginecology
RSUD Dr. Soetomo Surabaya Airlangga University
-
7/25/2019 5. Clinical Practice in Contraception-BUS
2/34
-
7/25/2019 5. Clinical Practice in Contraception-BUS
3/34
GREET :
Warm greetings
Fiendly meet
Keep secrets
HELP :
Choosing methods
Screening methods
ASK :
Age, parity, marriage
Number of childrens
History of contraception
EXPLAIN :
Mechanism of contraception
TELL :
Appropriate contraception
Contraception methods
Show the contraception device
RETURN :
When to comeback evaluation
Side effects
3
-
7/25/2019 5. Clinical Practice in Contraception-BUS
4/34
# Describe side effects of various methods, their frequency &duration
# Reassure re safety of methods
# Emphasize client satisfaction with methods in general
# Elicit & answer questions; correct misinformation courteously
-
7/25/2019 5. Clinical Practice in Contraception-BUS
5/34
# Elicit and respond to client concerns
# Be concise & clear
# Be honest re frequency or severity of side effects
# Provide support material
-
7/25/2019 5. Clinical Practice in Contraception-BUS
6/34
# Conventional/ Natural Method :
o
Calendar
o Coitus interruptus
o Lactational Amenorrhea
Method
# Barrier Methods:
o
Condoms (!and !)
o Diaphragms
o Spermicides
o
Foams , jelly ,tissue
# Progestin-Only Contraceptives:
o Norplant Implants
o Injectable
o Pills
# Combined Contraceptives:
o CICs
o COCs
# IUD :
o
CuT380A , Nova T ,
Lippes Loop . Multiload
#
Operative :
o Vasectomy
o Tubectomy
To AVOID sperm meets ovum
-
7/25/2019 5. Clinical Practice in Contraception-BUS
7/34
-
7/25/2019 5. Clinical Practice in Contraception-BUS
8/34
-
7/25/2019 5. Clinical Practice in Contraception-BUS
9/34
# Diaphragm: High Failure Rates
Must Remain in ~6 Hrs post-coitus
Best if Combined with Spermicide
UTI Potential# Condom: STD Protection, Inconsistent Use by Men
# Female Condom
# Today Sponge
-
7/25/2019 5. Clinical Practice in Contraception-BUS
10/34
# Cyclofem
25 mg depo-medroxyprogesterone acetate and 5 mg
estradiol cypionate injectable (IM) once a month
# Mesigyna
50 mg norethindrone enanthate and 5 mg estradiol
valerate injected (IM) once a month
-
7/25/2019 5. Clinical Practice in Contraception-BUS
11/34
Mechanism of Action CICs
-
7/25/2019 5. Clinical Practice in Contraception-BUS
12/34
# Anytime you can reasonably sure the client is not pregnant
# Days 1 7 of the menstrual cycle
# Postpartum:
after 6 months if using LAM
After 3 weeks if not breastfeeding
# Postabortion (immediately or within 7 days)
-
7/25/2019 5. Clinical Practice in Contraception-BUS
13/34
NoncontraceptivesBenefits
-
7/25/2019 5. Clinical Practice in Contraception-BUS
14/34
# Contain Synthetic Estrogen/Progestin
# Modern E2Dosage !50 Mcg
# Despite Diversity, Side Effects and Efficacies Similar
# Requires Patient Compliance
# May Be Monophasic or Triphasic
-
7/25/2019 5. Clinical Practice in Contraception-BUS
15/34
Suppress ovulation
Reduce sperm
transport in upper
genital tract (fallopian
tubes)
Change endometrium
making implantation
less likely
Thicken cervical mucus
(preventing sperm
penetration)
-
7/25/2019 5. Clinical Practice in Contraception-BUS
16/34
# Menstrual Regulation
# Decreased Risk of Anemia
#
Ovarian, Endometrial CA: Risk# Lower PID Risk
# Prevention of Benign Breast Disease
-
7/25/2019 5. Clinical Practice in Contraception-BUS
17/34
# Breakthrough Bleeding (!
25%)
#
Amenorrhea
# Breast Tenderness,
Nausea
#
?Weight Gain
-
7/25/2019 5. Clinical Practice in Contraception-BUS
18/34
# Thromboembolism (#35 yo, Smoker)
# MI (Smokers Only):
o < 15 cig/day: 3X Risk
o
> 15 cig/day : 21X Risk
# Liver Adenomas (Very Rare)
-
7/25/2019 5. Clinical Practice in Contraception-BUS
19/34
Injectable
# Inhibits Ovulation
# 150 mg 3 months (14 day grace period)
#
Delayed Ovulation After Discontinuation# Main Side-Effects:
o Amenorrhea
o AUB
o
Weight Gaino Hair Loss
-
7/25/2019 5. Clinical Practice in Contraception-BUS
20/34
Pills
$ Unlike the combined pill, the progestin-only pill
(sometimes called the mini-pill) only has one
hormone, progestin, instead of both estrogenand progestin.
$ It is prescribed by a doctor. It is taken at the
same time each day. It may be a good option forwomen who cant take estrogen.
$
Typical use failure rate: 9%.
-
7/25/2019 5. Clinical Practice in Contraception-BUS
21/34
# Implantable for !5 Years
# Similar Side Effects as Depo-Provera
# Avg. Yearly Failure Rate: 0.8/100 (Increases : > 2/100 after
5 years)
# Occasionally Difficult to Remove
-
7/25/2019 5. Clinical Practice in Contraception-BUS
22/34
-
7/25/2019 5. Clinical Practice in Contraception-BUS
23/34
-
7/25/2019 5. Clinical Practice in Contraception-BUS
24/34
# ParaGard (CuT380A), Progestasert
# Very Effective (~ TL), Reversable
# Risks OVERBLOWN
# Monogamy Essential, However
#
Does Not Protect Against STDs
# Can Remain for !10 Years
Types
-
7/25/2019 5. Clinical Practice in Contraception-BUS
25/34
-
7/25/2019 5. Clinical Practice in Contraception-BUS
26/34
-
7/25/2019 5. Clinical Practice in Contraception-BUS
27/34
# IUD, OCPs
# Specific OCP Regimens Given !72 Hours After Unprotected
Intercourse
~ 75% Effective
#Yuzpe Method: Ovral 2 tabs po now and 2 tabs 120later
# May Cause Nausea
# Consider Dispensing at Yearly Visit
-
7/25/2019 5. Clinical Practice in Contraception-BUS
28/34
FemalePrevents pregnancy by
preventing sperm from
reaching the egg
Prevents pregnancy by preventing
sperm from entering the semen; semen
is ejaculated without sperm
Male
-
7/25/2019 5. Clinical Practice in Contraception-BUS
29/34
Sterilization is appropriate for people who:
# Do not want any more children
# Want highly effective contraception
#
Want permanent protection
# Have difficulty with temporary methods requiring
compliance or resupply
There are no medical restrictions for age or parity.
Source: WHO, 2004; updated 2008.
-
7/25/2019 5. Clinical Practice in Contraception-BUS
30/34
It is IMPORTANT to distinguish side effects from rumors or
misinformation
o
Challenge: Clients believe that certain methods will render awoman sterile
o Solution: Always discuss returning to fertility as a significant
issue
-
7/25/2019 5. Clinical Practice in Contraception-BUS
31/34
Reasons
#Too Busy
# Worried that clients may
reject method(s)
Possible Solutions
#Reassure that counseling
can be brief. Provide
literature.
#Reassure that side effect
counseling increases use
continuation.
-
7/25/2019 5. Clinical Practice in Contraception-BUS
32/34
Reasons
#Unaware of frequency of
sides effects
# Lack of support material
Possible Solutions
# Give providers training on
common side effects.
# Provide simple written AV
materials for providers
-
7/25/2019 5. Clinical Practice in Contraception-BUS
33/34
# All Methods have Risks and May Not be
Appropriate for all Patients
# Give enough counceling
-
7/25/2019 5. Clinical Practice in Contraception-BUS
34/34